An AI-derived oocyte score is associated with IVF outcomes in a retrospective cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: The study analyzed 14,420 oocytes from 1,856 ICSI cycles using repeated patient-level validation, propensity weighting and mixed-effects analyses. The retrospective associations do not show that using the score improves live-birth outcomes or establish prospective clinical benefit.
Technology: The MAGENTA AI-derived score was evaluated for associations between oocyte features and fertilization and blastocyst outcomes.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The MAGENTA AI-derived score was evaluated for associations between oocyte features and fertilization and blastocyst outcomes.
- Test and result
- The study analyzed 14,420 oocytes from 1,856 ICSI cycles using repeated patient-level validation, propensity weighting and mixed-effects analyses.
- Limitation / still unknown
- The retrospective associations do not show that using the score improves live-birth outcomes or establish prospective clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1957168/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.